Maximize Returns with AI-Powered BNR Insights

BNR Forecast

What is Wall Street's Target Price for Burning Rock Biotech Ltd (BNR) Stock Monday? - InvestorsObserver

economy and finances

Wall Street is positive on Burning Rock Biotech Ltd (BNR). On average, analysts give the stock a Strong Buy rating. The average price target is $29.55, which means analysts expect the stock to increase by 172.85% over the next twelve months. That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver. Wall Street analysts are rating BNR a Strong Buy today. Find out what this means to you and get the rest of the rankings on BNR! See Full BNR Report Why are Analyst Ratings Important?

investorsobserver.com Dec 27, 2021

Market Forecasts

Bullish / Bearish

Digital Assets / Most Accurate

Trading Strategies

Long Volatility

Short Volatility

Balanced News

Balanced News / Sources

Tech / Memes / Politics

About

About / Pricing / Forum

Contact Helium Trades

2024 © Helium Trades
Privacy Policy & Disclosure

* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.